Clearbridge Health

Company in the news

Clearbridge Health's Indonesian subsidiary sued by JV partner

SINGAPORE (May 31): Clearbridge Health said its indirectly-held subsidiary in Indonesia has been sued by a joint venture partner in Jakarta,

CoVid-19

Regulators keep watch as companies jump on Covid-19 bandwagon

SINGAPORE (Apr 30): At the beginning of the Covid-19 outbreak back in January, listed glove-makers experienced a surge in their share price as investors scurried to scoop up these counters.

CoVid-19

Singapore firm Biolidics to launch rapid test kit to detect Covid-19 within 10 minutes

SINGAPORE (Mar 30): Singapore-based medical technology firm Biolidics announced Monday it is launching a rapid test kit for Covid-19 that can detect the coronavirus within 10 minutes, with a claime

Broker's Calls

This loss-making healthcare group could be a 'potential unicorn' and treble in value, says Tayrona

SINGAPORE (Feb 5): Emerging areas of precision medicine could transform loss-making healthcare group Clearbridge Health into a “potential unicorn in the making”, according to Tayrona Financial, the

Healthcare

Healthcare stocks get a shot in the arm as Wuhan virus fears rise

SINGAPORE (Jan 21): The outbreak of a new SARS-like virus originating in Wuhan, the capital of China’s Hubei province, is putting Asian stock markets on edge.

Equity raising

Clearbridge Health in private placement to raise $11.3 mil to speed up Asia growth plans

SINGAPORE (July 29): Clearbridge Health is raising $11.34 million from a share placement exercise to accelerate its growth plans in Asia’s healthcare market.

M&A

Clearbridge acquires 89.6% stake in Indonesia's IGM Labs for $9.4 mil

SINGAPORE (Apr 3): Clearbridge Health is acquiring a 89.6% stake in IGM Labs of Indonesia for $9.4 million or 2.8 times its EV/EBITDA.

Healthcare

Clearbridge subsidiary to issue $2 mil in convertible bonds

SINGAPORE (Mar 25): Clearbridge Health Limited’s subsidiary, Clearbridge Biophotonics, is set to issue $2 million in convertible bonds to develop its proprietary computational imaging microscopy te

IPO

Biolidics shares slump on Catalist debut

SINGAPORE (Dec 19): Just two hours into its debut on the Singapore Exchange (SGX) Catalist board, shares in medical technology firm Biolidics have slumped 23.2% from its listing price of 28 cents.

IPO

Biolidics selling 27.5 mil new shares at 28 cents each in conjunction with Catalist listing

SINGAPORE (Dec 11): Medtech company Biolidics is selling 27.5 million new shares at 28 cents each to retail and institutional investors in a private placement ahead of its listing on the Catalist B

Be informed of the stories that matter